Welcome to our dedicated page for Vicor SEC filings (Ticker: VICR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking design-win announcements and patent updates in Vicor’s SEC reports can feel like tracing voltage through a multilayer PCB. Each Vicor annual report 10-K spans intricate discussions of FPA™ architectures, customer concentration in hyperscale computing, and defense backlog—details critical yet time-consuming to extract.
Stock Titan solves that bottleneck. Our AI-powered summaries turn a 300-page document into a concise brief, so understanding Vicor SEC documents with AI becomes routine. Need the latest Vicor quarterly earnings report 10-Q filing? We ingest it in real time from EDGAR, highlight segment revenue trends, and compare R&D outlays quarter-over-quarter. Monitoring ownership shifts? Receive instant alerts for every Vicor Form 4 insider transactions real-time, complete with context on executive stock transactions and historical patterns.
Investors often ask, “Which new platforms adopted Vicor’s modular converters?” or “Did defense bookings grow this quarter?” The answers hide in multiple forms:
- 10-K and 10-Q: efficiency metrics, licensing revenue, and supply-chain risks—now Vicor SEC filings explained simply.
- 8-K: product qualification wins—Vicor 8-K material events explained in plain language.
- DEF 14A proxy: Vicor proxy statement executive compensation trends and governance insights.
- Form 4: Vicor insider trading Form 4 transactions summarized alongside peer activity.
Whether you’re conducting a Vicor earnings report filing analysis before a model update or verifying a Vicor executive stock transactions Form 4 prior to a trade, our expert commentary and AI highlights surface the nuggets that move the power-electronics market. All filings, all formats, delivered the moment they post—so you act before the circuit closes.
Vicor Corp (VICR): Corporate Vice President and Director Claudio Tuozzolo reported option exercises and same‑day sales on 10/23/2025.
He exercised 8,638 options at $33.96, 1,202 at $60.61, 866 at $75.43, and 3,931 at $41.61, then sold equivalent share amounts at $91.8648. Following these transactions, he directly owned 33,622 shares.
Vicor Corp (VICR) insider activity: Corporate VP - Marketing Robert Gendron reported transactions on 10/23/2025. He exercised stock options for 960 shares at $75.43 and 1,156 shares at $60.61, then sold 960 shares and 1,156 shares at $88.6811. Following these trades, he directly beneficially owned 5,374 shares. The filing also lists remaining option holdings.
Vicor Corp (VICR) officer Alvaro Doyle (VP and CIO) reported option exercises and same-day sales on 10/23/2025. He exercised 4,933 options at $41.61 and 2,891 options at $33.96, then sold 4,933 and 2,891 shares at an average price of $88.4819.
Following these transactions, direct beneficial ownership in common stock was 42 shares. Derivative holdings reported after the transactions included 7,398 options at a $41.61 exercise price and 11,561 options at a $33.96 exercise price. The filing notes that these options expire two years from each vesting date.
Vicor Corporation (VICR) director Andrew D'Amico reported exercising options and selling the resulting shares. Across 10/22/2025–10/23/2025, he exercised and sold a total of 15,242 shares, with exercises at strike prices ranging from $25.30 to $75.43 and sales at prices from $80 to $90. The transactions were made pursuant to a Rule 10b5-1 trading plan adopted on September 12, 2024.
The derivative table lists multiple non‑qualified stock option exercises tied to underlying common shares, with footnoted terms stating options expire 2 years from each vesting date.
Vicor (VICR) reported insider transactions by its CFO, Treasurer and Secretary, who is also a Director. On 10/22/2025, the reporting person exercised non‑qualified stock options and sold shares pursuant to a Rule 10b5‑1 trading plan adopted on December 13, 2024.
Exercises: 3,246 options at $41.61, 1,241 at $60.61, and 754 at $53.07. Sales: 3,246 shares at $80, 1,241 at $85, and 754 at $85. Following these transactions, the insider directly owned 875 shares of common stock.
Derivative holdings after the reported transactions include options covering 12,983 shares at $41.61, 3,722 shares at $60.61, and 3,015 shares at $53.07. The filing notes options expire two years from each vesting date.
Vicor Corp (VICR) director reported an option exercise and same‑day sale. On 10/21/2025, 1,000 shares were acquired via non‑qualified stock option exercise at $41.61 (Code M), and 1,000 shares were sold at $68 (Code S) pursuant to a Rule 10b5‑1 plan adopted on September 12, 2024. After these transactions, common stock directly held was 0, and 13,582 non‑qualified stock options were beneficially owned.
Vicor Corporation furnished an 8‑K announcing it issued a press release with financial results for the three and nine months ended September 30, 2025. The press release is attached as Exhibit 99.1 and is incorporated by reference.
The information under Item 2.02, including Exhibit 99.1, is furnished and not deemed “filed” under the Exchange Act. No pro forma financial information or shell company transactions were included.
Samuel J. Anderson, a director of Vicor Corp (VICR), reported option-related transactions dated 08/11/2025. The filing shows acquisition of 2,073 non-qualified stock options in three tranches: 1,217, 644, and 212 options with exercise prices of $32.89, $31.05, and $47.15, respectively. Following the reported transactions, Anderson's reported beneficial ownership of common stock is 5,864 shares.
The explanatory section states the options were originally granted on 6/21/2024, 6/28/2019, and 6/15/2018 under the company's Amended and Restated 2000 Stock Option and Incentive Plan and vest over a five-year period. The form was signed by Kemble D. Morrison as attorney-in-fact for Samuel J. Anderson on 08/13/2025.
Vicor (VICR) posted a sharp turnaround for Q2 2025. Total revenue plus a $45 m patent-litigation settlement reached $141.0 m; product+royalty revenue alone rose 11.9 % YoY to $96.0 m. Gross margin expanded to 65.3 % (47.1 % ex-settlement) and operating income jumped to $45.4 m from $0.2 m. Net income swung to $41.2 m ($0.91 diluted EPS) versus a $1.2 m loss in Q2 2024.
Growth was led by Advanced Products. Advanced revenue climbed 30.6 % to $60.6 m, while Brick Products fell 10.1 % to $35.5 m. Asia-Pacific sales surged 44 % and now represent 40 % of quarterly revenue; U.S. sales declined 5 %. Royalty income improved 11.6 % to $10.4 m.
Balance-sheet strength improved. Cash & equivalents increased $61 m Q-to-Q to $338.5 m, supported by $85.4 m operating cash flow and the settlement. Inventories fell 10 % YTD, while share repurchases totaled $17.6 m. The company remains debt-free but carries a $27.6 m litigation accrual tied to the SynQor patent case, with post-judgment interest still accruing. Backlog slipped 10 % sequentially to $155.2 m, hinting at potential near-term demand moderation.
FAQ
What is the current stock price of Vicor (VICR)?
What is the market cap of Vicor (VICR)?
